ES506386A0 - Procedimiento para la preparacion de mono-esteres amonio-al-cohilicos de acidos alcanol-fosforicos - Google Patents

Procedimiento para la preparacion de mono-esteres amonio-al-cohilicos de acidos alcanol-fosforicos

Info

Publication number
ES506386A0
ES506386A0 ES81506386A ES506386A ES506386A0 ES 506386 A0 ES506386 A0 ES 506386A0 ES 81506386 A ES81506386 A ES 81506386A ES 506386 A ES506386 A ES 506386A ES 506386 A0 ES506386 A0 ES 506386A0
Authority
ES
Spain
Prior art keywords
cohylics
alcanol
mono
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES81506386A
Other languages
English (en)
Other versions
ES8304147A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803039629 external-priority patent/DE3039629A1/de
Priority claimed from DE19813118965 external-priority patent/DE3118965A1/de
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of ES8304147A1 publication Critical patent/ES8304147A1/es
Publication of ES506386A0 publication Critical patent/ES506386A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/16Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165Esters of thiophosphoric acids
    • C07F9/1651Esters of thiophosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES81506386A 1980-10-21 1981-10-20 Procedimiento para la preparacion de mono-esteres amonio-al-cohilicos de acidos alcanol-fosforicos Granted ES506386A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803039629 DE3039629A1 (de) 1980-10-21 1980-10-21 Neue schwefelhaltige phospholipide, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE19813118965 DE3118965A1 (de) 1981-05-13 1981-05-13 Neue schwefelhaltige phospholipide, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
ES8304147A1 ES8304147A1 (es) 1983-03-01
ES506386A0 true ES506386A0 (es) 1983-03-01

Family

ID=25788614

Family Applications (1)

Application Number Title Priority Date Filing Date
ES81506386A Granted ES506386A0 (es) 1980-10-21 1981-10-20 Procedimiento para la preparacion de mono-esteres amonio-al-cohilicos de acidos alcanol-fosforicos

Country Status (10)

Country Link
US (1) US4444766A (es)
EP (1) EP0050327B1 (es)
CA (1) CA1174244A (es)
DD (1) DD201685A5 (es)
DE (1) DE3164332D1 (es)
ES (1) ES506386A0 (es)
HK (1) HK68987A (es)
HU (1) HU186789B (es)
SG (1) SG22187G (es)
SU (2) SU1241994A3 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3127503A1 (de) * 1981-07-11 1983-02-17 Boehringer Mannheim Gmbh, 6800 Mannheim Neue phospholipide, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4981989A (en) * 1984-12-10 1991-01-01 American Cyanamid Company Antihypertensive phosphate derivatives and intermediates thereof
US4619917A (en) * 1985-07-18 1986-10-28 Sandoz Pharm. Corp. Substituted 2-furanyl- or 5-oxo-2-furanyl methoxy phosphoryl alkyl cyclimmonium salts
CA2001401A1 (en) * 1988-10-25 1990-04-25 Claude Piantadosi Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
DE3906952A1 (de) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel
DE3929217A1 (de) * 1989-09-02 1991-03-07 Boehringer Mannheim Gmbh Verwendung von phospholipid-derivaten als antivirale arzneimittel und neue phospholipide
JPH0791301B2 (ja) * 1989-10-02 1995-10-04 新日本理化株式会社 ジアセタールの製造方法
ES2108715T3 (es) * 1991-07-04 1998-01-01 Asta Medica Ag Procedimiento para la preparacion de alquilfosfocolinas y purificacion de las mismas.
US6172050B1 (en) * 1992-07-11 2001-01-09 Asta Medica Aktiengesellschaft Phospholipid derivatives
DE4222910A1 (de) * 1992-07-11 1994-01-13 Asta Medica Ag Neue Phospholipidderivate
WO1994002153A1 (en) * 1992-07-22 1994-02-03 Boehringer Mannheim Gmbh Use of sulphur containing phospholipids for treating leishmaniasis
US5489580A (en) * 1992-11-05 1996-02-06 University Of Connecticut Phospholipid compounds and use therefor
EP0702556B1 (en) * 1993-06-10 2002-10-23 Wake Forest University (phospho)lipids for combatting hepatitis b virus infection
US5610198A (en) * 1994-03-18 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases
WO1996006620A2 (en) * 1994-08-29 1996-03-07 Wake Forest University Lipid analogs for treating viral infections
US7135584B2 (en) * 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
TW343975B (en) * 1995-12-15 1998-11-01 Boehringer Mannheim Gmbh New phospholipid derivatives of phosphonocarboxylic acids, the production thereof as well as their use as antiviral pharmaceutical agents
EP0916654B1 (en) * 1996-08-02 2005-02-23 Kaneka Corporation Sulfonic ester derivatives, process for preparing the same, and use thereof
US7026469B2 (en) * 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
JP2004520175A (ja) * 2001-05-29 2004-07-08 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 金属−セラミック接合
US7551837B2 (en) * 2001-08-31 2009-06-23 Thomson Licensing Sequence counter for an audio visual stream
US20050187192A1 (en) * 2004-02-20 2005-08-25 Kucera Pharmaceutical Company Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
US20050187191A1 (en) * 2004-02-20 2005-08-25 Kucera Louis S. Methods and compositions for the treatment of respiratory syncytial virus
ES2629682T3 (es) 2004-03-29 2017-08-14 University Of South Florida Tratamiento efectivo de tumores y cáncer con fosfato de triciribina
WO2006110656A2 (en) * 2005-04-08 2006-10-19 Chimerix, Inc. Compounds, compositions and methods for the treatment of viral infections and other medical disorders
US8642577B2 (en) 2005-04-08 2014-02-04 Chimerix, Inc. Compounds, compositions and methods for the treatment of poxvirus infections
US8741966B2 (en) 2007-11-09 2014-06-03 Pronova Biopharma Norge As Lipid compounds for use in cosmetic products, as food supplement or as a medicament
EP2254582B1 (en) * 2008-01-25 2016-01-20 Chimerix, Inc. Methods of treating viral infections
EP2147910A1 (en) 2008-07-15 2010-01-27 Pronova BioPharma Norge AS Novel lipid compounds
MX366137B (es) 2009-05-08 2019-06-28 Pronova Biopharma Norge As Acidos grasos poliinsaturados para el tratamiento de trastornos relacionados a las areas de los trastornos cardiovasculares, metabolicos e inflamatorios.
WO2011011519A1 (en) 2009-07-21 2011-01-27 Chimerix, Inc. Compounds, compositions and methods for treating ocular conditions
WO2011100698A2 (en) 2010-02-12 2011-08-18 Chimerix, Inc. Methods of treating viral infection
EP2563367A4 (en) 2010-04-26 2013-12-04 Chimerix Inc METHODS OF TREATING RETROVIRAL INFECTIONS AND ASSOCIATED DOSAGE REGIMES
MX350720B (es) 2010-11-05 2017-09-14 Pronova Biopharma Norge As Metodos de tratamiento usando compuestos lipidos.
EP2961384B1 (en) 2013-02-28 2019-08-28 Basf As A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
JP6784696B2 (ja) 2015-04-28 2020-11-11 プロノヴァ バイオファーマ ノルゲ エーエス 硫黄を含有する構造的に強化された脂肪酸の非アルコール性脂肪性肝炎の予防及び/又は治療のための使用
US11925614B2 (en) 2017-12-06 2024-03-12 Basf As Fatty acid derivatives for treating non-alcoholic steatohepatitis
LU101206B1 (en) * 2019-05-06 2020-11-06 Univ Luxembourg PDEdelta Inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1543937C3 (de) * 1966-01-14 1982-12-09 Unilever N.V., 3000 Rotterdam Verwendung modifizierter kephalinhaltiger Phosphatidgemische als Emulgatoren für O/W-Emulsionen und Verfahren zur Herstellung solcher Emulgatoren
US4119714A (en) * 1970-02-27 1978-10-10 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E. V. Glycerin-alkylether-(1)-phosphoric acid-(3)-monocholine esters as enhancers of the natural resistance of the mammalian organism against non-carcinogenic pathogens
DE2009341C3 (de) * 1970-02-27 1979-06-21 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen 3-Octadecyloxy-propanol-(l)-phosphorsäure-monocholinester und Verfahren zu dessen Herstellung
DE2033359C3 (de) * 1970-07-06 1980-02-14 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Acylpropandiol-(l,3)-phosphorsäuremono-cholinester und Verfahren zu deren Herstellung
US4159988A (en) * 1974-08-06 1979-07-03 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Synthetic phospholipids, a process for their manufacture and their use
DE2619686C2 (de) * 1976-05-04 1986-08-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verwendung eines Lysolecithins zur Tumorbehandlung
DE2619715A1 (de) * 1976-05-04 1977-11-24 Max Planck Gesellschaft Tumor-antigen und verfahren zu dessen herstellung
DE2642661C2 (de) * 1976-09-22 1984-06-28 A. Nattermann & Cie GmbH, 5000 Köln Acetoin-dialkyl-phosphorsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung
JPS55118494A (en) * 1979-03-07 1980-09-11 Toyama Chem Co Ltd Novel phosphorylcholine compound, its preparation, and antitumor agent comprising it
US4329302A (en) * 1980-06-27 1982-05-11 Board Of Regents, The University Of Texas System Synthetic phosphoglycerides possessing platelet activating properties
DE3025804C2 (de) * 1980-07-08 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln 1-S-Alkyl-2-0-acyl-3-phosphocholin-1-mercapto-2,3-propandiole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
ES8304147A1 (es) 1983-03-01
SU1241994A3 (ru) 1986-06-30
EP0050327A1 (de) 1982-04-28
SG22187G (en) 1987-11-13
HK68987A (en) 1987-10-02
EP0050327B1 (de) 1984-06-20
DD201685A5 (de) 1983-08-03
US4444766A (en) 1984-04-24
CA1174244A (en) 1984-09-11
HU186789B (en) 1985-09-30
DE3164332D1 (en) 1984-07-26
SU1376948A3 (ru) 1988-02-23

Similar Documents

Publication Publication Date Title
ES506386A0 (es) Procedimiento para la preparacion de mono-esteres amonio-al-cohilicos de acidos alcanol-fosforicos
MX6869E (es) Procedimiento para la preparacion de dibenzimidiazoazepinas
ES502546A0 (es) Procedimiento para la preparacion de nuevas n-ariloxazolidi-nonas-2
AR228468A1 (es) Procedimiento para la preparacion de nuevas imidazolil-fenilamidinas
AR226202A1 (es) Procedimiento para la preparacion de 7-acil-3-yodometil-cefalosporinas
ES530045A0 (es) Procedimiento para la obtencion de acidos quinoloncarboxilicos
MX160977A (es) Procedimiento para la preparacion de cloroformiatos alfa-clorados
ES514699A0 (es) Procedimiento para preparar esteres de acidos quinolina-car boxilicos.
ES496382A0 (es) Procedimiento para la preparacion de acidos oxocarboxilicos sustituidos
AR227906A1 (es) Procedimiento para la preparacion de derivados de 1-fenil-2-ciclohexen-1-alquilamina
ES501464A0 (es) Procedimiento para la preparacion de nuevas fenilureas
MX157134A (es) Procedimiento para la obtencion de acidos hidroxicarboxilicos aromaticos
ES499729A0 (es) Procedimiento para la preparacion de derivados de fenoxi- aminopropanol
ES503975A0 (es) Procedimiento para la preparacion de nuevas fenilureas
ES500071A0 (es) Procedimiento para la preparacion de nuevos 2-nitro-5-feno- xifenil-oxazoles,-oxacinas,-imidazoles,-pirimidinas o-tiazo-les
MX6707E (es) Procedimiento para la preparacion de n(1-alil-2-pirrolidinilmetil)-2-metoxi-4-amino-5-metil-sulfamoil-benzamida
AR229350A1 (es) Procedimiento para la preparacion de nuevas guanilamidinas
ES505095A0 (es) Procedimiento para la preparacion de nuevas pirazinas
AR221386A1 (es) Procedimiento para la preparacion de esteres basicos de acidos hidroxiciclohexancarboxilicos sustituidos
ES499356A0 (es) Procedimiento para la preparacion de derivados de rifamicina
ES505324A0 (es) Procedimiento para la preparacion de 4-carbamoiloxi-oxaza- fosforinas
ES499209A0 (es) Procedimiento para la preparacion de 3-desoxi-a15-esteroides
ES499510A0 (es) Procedimiento para la preparacion de acidos 5-sulfamoilorta-nilicos
MX155820A (es) Procedimiento para la preparacion de acidos alcansulfonicos substancialmente anhidros
ES499358A0 (es) Procedimiento para la preparacion de esteres de acidos aril-propionicos